Business Segments · D&A
Consumer Tissue — D&A
Kimberly-Clark Consumer Tissue — D&A remained flat by 0.0% to $59.00M in Q4 2023 compared to the prior quarter. Year-over-year, this metric declined by 6.0%, from $62.75M to $59.00M. Over 2 years (FY 2021 to FY 2023), Consumer Tissue — D&A shows a downward trend with a -9.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2021
Last reportedQ1 2026
Rolls up toD&A
How to read this metric
High levels relative to revenue may indicate a capital-intensive manufacturing footprint.
Detailed definition
The non-cash expense allocated to the Consumer Tissue segment to account for the gradual wear and tear of physical asset...
Peer comparison
Standard operating expense metric for manufacturing segments.
Metric ID:
kmb_segment_consumer_tissue_depreciation_and_amortizationHistorical Data
3 years
| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $291.00M | $251.00M | $236.00M |
| YoY Change | — | -13.7% | -6.0% |
Range$236.00M – $291.00M
CAGR-9.9%
Avg YoY Growth-9.9%
Median YoY Growth-9.9%
Current Streak2+ years decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Kimberly-Clark's consumer tissue — d&a?
- Kimberly-Clark (KMB) reported consumer tissue — d&a of $59.00M in Q4 2023.
- How has Kimberly-Clark's consumer tissue — d&a changed year-over-year?
- Kimberly-Clark's consumer tissue — d&a decreased by 6.0% year-over-year, from $62.75M to $59.00M.
- What is the long-term trend for Kimberly-Clark's consumer tissue — d&a?
- Over 2 years (2021 to 2023), Kimberly-Clark's consumer tissue — d&a has grown at a -9.9% compound annual growth rate (CAGR), from $291.00M to $236.00M.
- What does consumer tissue — d&a mean?
- The non-cash cost of using up physical and intangible assets in the Consumer Tissue segment.